ArcelorMittal SA (MTS)
Madrid Exchange · Spain · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 53.90 |
|---|---|
| 52-week range | 31.87 – 68.52 |
| Return, 1 month / 3 months | −15.6% / −7.2% |
| Return, 1 year / 3 years | +63.1% / +177.2% |
| Trend | Below its 200-day average |
| RSI (14) | 31 |
| Volatility (1 year) | 41.3% |
| Worst drawdown (1 year) | -26.2% |
| Average daily value traded | 10.17M EUR |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ArcelorMittal is a steel and mining company headquartered in Luxembourg. It makes flat and long steel products, including sheet and plate steel, wire rod, rails and structural sections, and also produces iron ore through its mining operations. Its customers come from industries such as automotive, construction, machinery, appliances and packaging, and it serves markets across Europe, the Americas, Asia and Africa. The company also operates research and development facilities that work on steelmaking processes and new steel products.
ArcelorMittal SA trades under the code MTS on the Madrid Exchange in Spain, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ArcelorMittal SA (MTS) trades on the Madrid Exchange in Spain. It last closed at EUR 53.90 on 22 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 113 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 63.1% and over the last three months it fell 7.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.9% | ||
| From 52-week high | -20.2% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.2% | ||
| 6-month return | 3.6% | ||
| 12-month return, skipping the last month | 93.3% | ||
| Stability (higher is calmer) | 28 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 41.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.2% | ||
| Liquidity | 89 · Strong | Trades actively. | |
| Average daily value traded | 10.17M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 29 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.8% |
|---|---|
| 1 month | −15.6% |
| 3 months | −7.2% |
| 6 months | +3.6% |
| 1 year | +63.1% |
| 3 years | +177.2% |
| 5 years | +113.2% |
Signals
| 50-day / 200-day average | 61.29 / 54.93 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.90 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Aug 2026 | EUR 0.1300 |
| 12 May 2026 | EUR 0.1278 |
| 12 Feb 2026 | EUR 0.1262 |
| 12 Nov 2025 | EUR 0.2377 |
| 15 May 2025 | EUR 0.2458 |
| 11 Nov 2024 | EUR 0.2318 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.